BridgeBio Pharma (BBIO) Total Liabilities (Quarterly): 3.815B

BridgeBio Pharma, Inc. (BBIO)

78.17 -1.37 (-1.72%) USD | NASDAQ | Nov 12, 16:00

78.40 +0.23 (+0.29%) After-Hours: 07:32

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
September 30, 2026	3.815B
June 30, 2026	3.723B
March 31, 2026	3.640B
December 31, 2025	3.013B
September 30, 2025	2.921B
June 30, 2025	2.859B
March 31, 2025	2.520B
December 31, 2024	2.377B
September 30, 2024	1.883B
June 30, 2024	1.876B
March 31, 2024	1.886B
December 31, 2023	1.889B
September 30, 2023	1.849B
June 30, 2023	1.853B
March 31, 2023	1.839B
December 31, 2022	1.868B

Date	Value
September 30, 2022	1.859B
June 30, 2022	1.877B
March 31, 2022	1.854B
December 31, 2021	1.878B
September 30, 2021	1.517B
June 30, 2021	1.537B
March 31, 2021	1.481B
December 31, 2020	595.70M
September 30, 2020	569.31M
June 30, 2020	577.72M
March 31, 2020	537.73M
December 31, 2019	155.70M
September 30, 2019	116.26M
June 30, 2019	593.09M
March 31, 2019	569.76M
December 31, 2018	566.44M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks